EAM
PRAX icon

Exome Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Exome Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.11M Sell
27,205
-18,264
-40% -$5.78M 5.62% 2
2026
Q1 		$14.6M Sell
45,469
-12,653
-22% -$3.91M 7.58% 1
2025
Q4 		$17.1M Sell
58,122
-43,874
-43% -$8.17M 8.19% 1
2025
Q3 		$5.41M Buy
101,996
+42,994
+73% +$2.08M 3.27% 8
2025
Q2 		$2.48M Buy
+59,002
New +$2.25M 1.84% 21

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Exome Asset Management's PRAX Position: Q2 2026 in Review

Exome Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 40% in Q2 2026, selling an estimated $5.78M and leaving 27,205 shares worth $9.11M. The position accounts for 5.62% of the portfolio, ranked #2.

Exome Asset Management first reported a position in PRAX in Q2 2025 and has held it in 5 quarters since. The position peaked at $17.1M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Exome Asset Management held 27,205 shares of Praxis Precision Medicines worth $9.11M as of Q2 2026.
  • Exome Asset Management sold 18,264 Praxis Precision Medicines shares in Q2 2026, an estimated $5.78M.
  • Praxis Precision Medicines made up 5.62% of Exome Asset Management's portfolio in Q2 2026, its #2 holding.
  • Exome Asset Management first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 5 quarters since.
  • Exome Asset Management's Praxis Precision Medicines position peaked at $17.1M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.